Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NSAID-related ulcer treatments

This article was originally published in The Tan Sheet

Executive Summary

Omeprazole heals and prevents ulcers more effectively than ranitidine in patients who use nonsteroidal anti-inflammatory drugs regularly, Neville Yeomans, MD, University of Melbourne, Australia, et al., report in a study in the March 12 New England Journal of Medicine. The study, involving 541 patients, compared 20 mg omeprazole per day or 150 mg ranitidine twice daily, the Rx dose of the H2 antagonist. In another study published in the same issue of NEJM, Christopher Hawkey, MD, University Hospital, Nottingham, U.K., et al., found that omeprazole and misoprostol were equally effective at treating ulcers, G.I. erosions and symptoms associated with NSAIDs. However, "maintenance therapy with omeprazole was associated with a lower rate of relapse than misoprostol," the researchers noted. The study's 935 subjects were given either 20 mg or 40 mg of omeprazole daily or 200 þg misoprostol four times daily. Astra Merck is considering an Rx-to-OTC switch for omeprazole (Prilosec)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088215

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel